Page last updated: 2024-09-05

lapatinib and filipin

lapatinib has been researched along with filipin in 1 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (filipin)	Trials (filipin)	Recent Studies (post-2010) (filipin)
1,919	305	1,442	767	0	105

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hou, S; Lei, H; Li, Q; Liu, F; Liu, H; Liu, S; Wang, D; Wang, S; Wang, T; Wu, Y; Xu, L; Zaky, MY; Zhang, J; Zhang, Y; Zou, K; Zou, L	1

Other Studies

1 other study(ies) available for lapatinib and filipin

Article	Year
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer. Cell communication and signaling : CCS, 2019, 02-20, Volume: 17, Issue:1 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cholesterol; Drug Synergism; Endocytosis; Female; Filipin; Humans; Lapatinib; Lovastatin; Mice, Nude; Models, Biological; Protein Kinase Inhibitors; Proteolysis; Receptor, ErbB-2; Xenograft Model Antitumor Assays	2019

Article

Year

Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer.

Cell communication and signaling : CCS, 2019, 02-20, Volume: 17, Issue:1

Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cholesterol; Drug Synergism; Endocytosis; Female; Filipin; Humans; Lapatinib; Lovastatin; Mice, Nude; Models, Biological; Protein Kinase Inhibitors; Proteolysis; Receptor, ErbB-2; Xenograft Model Antitumor Assays

2019